Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Clearpoint Neuro Inc
(NQ:
CLPT
)
7.210
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,927
Open
7.210
Bid (Size)
7.040 (30)
Ask (Size)
7.250 (8)
Prev. Close
7.210
Today's Range
7.210 - 7.210
52wk Range
4.050 - 7.970
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
7 Growth Stocks That Could 5X in 5 Years
July 17, 2024
These top growth stocks across various sectors have the potential to deliver 5X returns in just five years.
Via
InvestorPlace
CLPT Stock Earnings: ClearPoint Neuro Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
CLPT stock results show that ClearPoint Neuro beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
+6.66%
+6.66%
1 Month
+30.85%
+30.85%
3 Month
+30.85%
+30.85%
6 Month
-7.09%
-7.09%
1 Year
+6.34%
+6.34%
More News
Read More
7 Penny Stocks That Could Make You a Fortune (If You Dare)
May 01, 2024
Via
InvestorPlace
The 3 Most Promising MedTech Stocks to Invest In Now
April 11, 2024
Via
InvestorPlace
ClearPoint Neuro: Q4 Earnings Insights
March 12, 2024
Via
Benzinga
Earnings Outlook For ClearPoint Neuro
March 11, 2024
Via
Benzinga
ClearPoint Neuro: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
ClearPoint Neuro: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Earnings Scheduled For March 12, 2024
March 12, 2024
Via
Benzinga
The Top 7 Under-$15 Stocks to Buy in March 2024
March 07, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 28, 2024
Via
Benzinga
Tech Trailblazers: 7 Small-Cap Stocks on the Verge of a Breakthrough
February 28, 2024
Via
InvestorPlace
The 3 Up-and-Coming Stocks That Could Make Your February Unforgettable
February 15, 2024
Via
InvestorPlace
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
February 15, 2024
Via
InvestorPlace
3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List
February 09, 2024
Via
InvestorPlace
3 Small-Cap Healthcare Stocks to Buy and Hold Forever: January 2024
January 25, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
7 Small-Cap Stocks With Huge Potential Flying Under the Radar
January 10, 2024
Via
InvestorPlace
7 Solid Small-Caps for 2024 and Beyond
December 05, 2023
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
Via
Benzinga
Top 5 Health Care Stocks That Are Set To Fly In Q2
June 09, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
June 05, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 28, 2023
Via
Benzinga
3 High-Potential Small-Cap Stocks for Investors With Strong Stomachs
May 31, 2023
Via
InvestorPlace
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
May 24, 2023
From
ClearPoint Neuro, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
